(5-{1-[(tert-butoxycarbonyl)amino]ethyl}-4H-1,2,4-triazol-3-yl)acetic acid, 95.0%, 10g

Elution Tubes ROTI® MAXI, 3,5 kDa, 30 Piece(s)

2-Nitroisophthalic acid, 95.0%, 100g

(5-Bromo-4-fluoro-2-nitro-phenyl)-methyl-amine, 95.0%, 100mg

2-Methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline, 97.0%, 25g

5-HYDROXY-7-METHOXY-2-METHYL-4H-CHROMEN-4-ONE, 95.0%, 50mg

(2R,3R)-3-(2,5-DIFLUOROPHENYL)-3-HYDROXY-2-METHYL-4-(1H-1,2,4-TRIAZOL-1-YL)BUTANOIC ACID, 97.0%, 100mg

ac-d-ala-oh, 95.0%, 5g

O-(Propargyl)-N-(triethoxysilylpropyl)carbamate (inhibited with MEHQ), 90%, 5g

Headspace vials ROTILABO® with beaded rim ND20 rounded bottom, Clear glass with labelling area, bevelled headspace edge, 20 ml, 100 Piece(s)

Methyl 3-(Trifluoromethyl)benzoate>98.0%(GC)5g

(4-Pyrrol-1-yl-phenyl)-acetic acid, 95.0%, 2.5g

2,5-Diaminobenzotrifluoride, 98.0%, 100g